Isabel Lemos
Overview
Explore the profile of Isabel Lemos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mendes C, Lemos I, Hipolito A, Abreu B, Freitas-Dias C, Martins F, et al.
Biosci Rep
. 2024 Jul;
44(7).
PMID: 38990147
Lung cancer ranks as the predominant cause of cancer-related mortalities on a global scale. Despite progress in therapeutic interventions, encompassing surgical procedures, radiation, chemotherapy, targeted therapies and immunotherapy, the overall...
2.
Freitas-Dias C, Goncalves F, Martins F, Lemos I, Goncalves L, Serpa J
Cells
. 2024 Feb;
13(4.
PMID: 38391918
Background: Cancer-associated thrombosis (CAT) and venous thromboembolism (VTE) are frequent cancer-related complications associated with high mortality; thus, this urges the identification of predictive markers. Immune checkpoint inhibitors (ICIs) used in...
3.
Hipolito A, Mendes C, Martins F, Lemos I, Francisco I, Cunha F, et al.
Antioxidants (Basel)
. 2024 Jan;
13(1).
PMID: 38247476
Lung cancer is a lethal disease with no truly efficient therapeutic management despite the progresses, and metabolic profiling can be a way of stratifying patients who may benefit from new...
4.
Hipolito A, Xavier R, Brito C, Tomas A, Lemos I, Cabaco L, et al.
Biochim Biophys Acta Mol Basis Dis
. 2023 Dec;
1870(2):166983.
PMID: 38070581
Cutaneous melanoma (CM) is the most aggressive skin cancer, showing globally increasing incidence. Hereditary CM accounts for a significant percentage (5-15 %) of all CM cases. However, most familial cases...
5.
Mendes C, Lemos I, Francisco I, Almodovar T, Cunha F, Albuquerque C, et al.
Lung Cancer
. 2023 Jun;
182:107283.
PMID: 37379672
Background: Metabolic remodeling is crucial in carcinogenesis and cancer progression. Oncogenic mutations may promote metabolic reprogramming in cancer cells to support their energy and biomass requirements. EGFR mutations are commonly...
6.
Flores A, Lemos I, Rema A, Taulescu M, Seixas F, Reis C, et al.
Vet Comp Oncol
. 2020 Mar;
18(4):615-625.
PMID: 32134186
Malignant transformation is often associated with abnormal protein glycosylation expressed, amongst others, by the accumulation of simple mucin-type carbohydrates namely Tn and Sialyl-Tn (STn) antigens. These are usually limited in...